Arcus Biosciences, Inc. (RCUS)
23.87
+0.13
(+0.55%)
USD |
NYSE |
May 21, 16:00
23.92
+0.04
(+0.19%)
After-Hours: 19:59
Arcus Biosciences Total Assets (Quarterly) : 997.00M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 56.28B |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Catalyst Pharmaceuticals, Inc. | 1.148B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 473.00M |
| Shareholders Equity (Quarterly) | 524.00M |
| Debt to Equity Ratio | 0.2156 |
| Current Ratio | 4.038 |
| Net Debt Paydown Yield | 0.34% |